Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-219

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 25021-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dec0b 0000 01)

Structural Formula (Dec0b 0000 01)
Chemical structure of Decitabine showing its nucleoside analog framework, including a modified pyrimidine base attached to a sugar moiety with indicated carbon positions and functional groups.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dec0b 0000 02)

Package Label – Principal Display Panel – Vial Label (Dec0b 0000 02)
Decitabine for Injection 50 mg per vial label for intravenous use. The label states it is a single-dose sterile vial, with a warning for cytotoxicity. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in China. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.